ClinConnect ClinConnect Logo
Search / Trial NCT05390541

Increasing HIV/STI Home Testing Via a Digital Intervention Among Black Women

Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · May 19, 2022

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on helping Black women who are at risk for HIV and sexually transmitted infections (STIs) to get tested for these conditions more easily from home. The study is testing a digital program that provides support and information on how to use home testing kits, connect with healthcare services, and learn about preventive treatments like PrEP, which can help reduce the risk of getting HIV.

To participate, women must be between the ages of 15 and 59, identify as Black or African-American, and live in urban areas like Austin, Dallas, Houston, or San Antonio in Texas. They should not have tested for HIV or STIs in the past year and should have had condom-less sex in the past six months. Participants will receive guidance through the digital program, making it easier for them to get tested and access care. This trial aims to make testing more accessible and tailored to the needs of the community, ultimately helping to improve health outcomes for women at risk.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 15 - 59 years of age
  • Identify as a cisgender woman
  • Identify as Black/African-American (Black/African American mixed race/ethnicity is included)
  • Read/speak/type in English
  • Have not tested for HIV/STIs in the past 12 months
  • Live in urban or suburban areas in Austin, Dallas, Houston, or San Antonio, Texas
  • Had condom-less sex in the past 6 months
  • Have access to a device (i.e., smart phone, tablet, or computer/laptop)
  • Have access to the internet
  • * Reports at least one of the following:
  • A sexual partner who is living with HIV
  • Does not use or uses condoms inconsistently for vaginal/anal sex
  • Injects drugs with a partner who is living with HIV
  • Shared drug preparation or injection equipment with others
  • Exclusion Criteria:
  • Over the age of 59 or younger than 15 years
  • Identify as any gender other than a cisgender woman
  • Identify as any race/ethnicity other than Black/African-American
  • Are unable to fluently speak, read, or type in English
  • Had an HIV/STI test within the past 12 months
  • Live in rural areas of Texas or urban/suburban areas other than Austin, Dallas, Houston, or San Antonio, Texas
  • Use condoms 100% of the time during vaginal/anal sex in the past 6 months
  • Do not have access to a device (i.e., smart phone, tablet, or computer/laptop)
  • Do not have access to the internet
  • Reports that they do not have a sexual partner who is living with HIV, always uses condoms for vaginal/anal sex, does not inject drugs with a partner living with HIV, and does not share drug preparation or injection equipment with others.

About Johns Hopkins Bloomberg School Of Public Health

The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.

Locations

Austin, Texas, United States

Austin, Texas, United States

Dallas, Texas, United States

Houston, Texas, United States

San Antonio, Texas, United States

Patients applied

0 patients applied

Trial Officials

Liesl A Nydegger, PhD

Principal Investigator

Johns Hopkins Bloomberg School of Public Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials